Mirae Asset Global ETFs Holdings
BIOA

Mirae Asset Global ETFs Holdings’s BioAge Labs BIOA Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$248K Buy
14,155
+3,146
+29% +$60.6K ﹤0.01% 2239
2025
Q4 		$146K Sell
11,009
-127
-1% -$1.13K ﹤0.01% 2495
2025
Q3 		$65.5K Sell
11,136
-1,819
-14% -$8.52K ﹤0.01% 2855
2025
Q2 		$53.5K Buy
12,955
+5,976
+86% +$24.1K ﹤0.01% 2867
2025
Q1 		$26.2K Buy
6,979
+312
+5% +$1.44K ﹤0.01% 2952
2024
Q4 		$38.6K Buy
+6,667
New +$115K ﹤0.01% 2941

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's BIOA Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings increased its BioAge Labs (BIOA) stake by 29% in Q1 2026, buying an estimated $60.6K and bringing the position to 14,155 shares worth $248K. The position accounts for ﹤0.01% of the portfolio, ranked #2239.

Mirae Asset Global ETFs Holdings first reported a position in BIOA in Q4 2024 and has held it in 6 quarters since. 144 funds tracked by Wall St. Rank hold BIOA as of Q1 2026.

  • Mirae Asset Global ETFs Holdings held 14,155 shares of BioAge Labs worth $248K as of Q1 2026.
  • Mirae Asset Global ETFs Holdings bought 3,146 BioAge Labs shares in Q1 2026, an estimated $60.6K.
  • BioAge Labs made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #2239 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in BioAge Labs in Q4 2024 and has held it in 6 quarters since.
  • 144 funds tracked by Wall St. Rank held BioAge Labs as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.